Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc (TRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations GlobeNewswire - Mon Apr 20, 8:15AM CDT

Focused on protecting and returning value of  Jemperli and imsidolimab royalties to shareholders Launches with virtual model, including limited FTEs and minimal operating expenses, and approximately...

ANAB : 57.98 (+0.36%)
TRAX : 16.20 (-5.01%)
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases GlobeNewswire - Mon Apr 20, 8:15AM CDT

First Tracks Biotherapeutics launches with $180 million in cash and two-year cash-runway Trading of TRAX begins on Nasdaq today SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics,...

TRAX : 16.20 (-5.01%)
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update GlobeNewswire - Fri Mar 27, 8:00AM CDT

Anaptys to spin-off biopharma operations into First Tracks Biotherapeutics, with a target distribution date of April 20, 2026 Anaptys to manage the financial collaborations for Jemperli with GSK and...

ANAB : 57.98 (+0.36%)
TRAX : 16.20 (-5.01%)

Barchart Exclusives

Up 840% in the Past Year, the Signal for Viasat Stock Is Getting a Little Fuzzy Barchart - 59 seconds ago
Viasat (VSAT) has surged 839% over the past year, with strong technical momentum and a Trend Seeker “Buy” signal since April. VSAT trades at $86.25, well above its 50-day moving average, but fundamentals show a lofty valuation and mixed analyst sentiment. Analysts project modest revenue growth and a sharp earnings... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.